For instance, in patients with PAD, mRNAs of P‐selectin glycoprotein ligand (SELPG), ICAM1, ITGA6, (F11R), and NF‐κB are all up‐regulated targets of PAD‐specific miRNAs. Here, ITGA6 is linked to peripheral arterial disease.